Aerosolve Tent

The Aerosolve Tent is a portable procedural tent which creates a larger negative pressure environment intended for use during a broader array of medical procedures.

Value Proposition

The portable negative pressure tent allows physicians to perform various procedures on COVID or other infectious patients that they would otherwise not be able to perform due to the risk of virus transmission. Aerosolve devices enable much needed “clinical distancing”. Using the Aerosolve Tent, doctors at Michigan Medicine were able to take patients off ventilators 7-10 days earlier and performed high-risk procedures including tracheostomy, bronchoscopy, extubation, etc.

Competitive Advantage

  • Comfortable: allows the patient to be supine, semi-recumbent, or seated upright

  • Mitigates need for negative pressure rooms

  • Improved confidence and comfort among healthcare workers

  • Allows for a greater number of patient procedures than other proposed solutions

  • Transportable across care environments

Unique Features

  • Multiple access points allow a greater number of medical and surgical procedures

  • The device can be used with conventional operating tables and other standard surgical equipment

  • 50 times greater number of air exchanges than a Negative Pressure Room (NPR)

  • Lower cost components like the tent itself are “throw away” eliminating costly and time consuming decontamination. More expensive components like the blower motor are retained.

Licensed These products have established agreements with companies and/or manufacturers.

Licensing Information
InspireRx, LLC in 2020

Principal Investigators
Kevin Ward, MD
Ben Bassin, MD
Nathan Haas, MD
Sridhar Kota, PhD

Intellectual Property
Invention Disclosure # 2020-383
Patent Applications Submitted

Solution Sheet
Download Solution Sheet (PDF)

Image courtesy of project team

MARKET OPPORTUNITY
The disposable equipment is single-use, and we estimate that the disposable portion of the system will cost approximately $80 to produce and will cost facilities $125 per unit. InspireRx has received EUA approval from the FDA and is seeking additional funding to help cover manufacturing and distribution costs.

Contact InspireRx for more information about investment and partnership opportunities.

Funding History

Substantial additional departmental, school and center based support

Funding Organizations

LicensedKate Murphy